Anlon Healthcare Ltd

NSE: AHCL · BSE: 544497 · Pharmaceuticals & Biotechnology · 43 announcements

Share price: ₹28.18
Market cap: ₹149.8 Cr
Revenue (annual): ₹172.0 Cr
Net profit (annual): ₹28.51 Cr
P/E (TTM): 4.7×Sector 47.3×
Promoter holding: 52.68%+0.00% QoQ
FII holding: 1.67%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

31 Jul 2026 10:44 IST NSE

Anlon Healthcare Results Update

Anlon Healthcare Limited reported Q1FY27 consolidated net profit growth of 133% to ₹8.28 Crore. Total income rose 163% to ₹87.62 Crore, driven by strategic acquisitions.

Value: ₹8.28 Cr

Read the filing ↗

30 May 2026 11:31 IST NSE

Results Update

Anlon Healthcare Results Update

Anlon Healthcare reported FY26 consolidated revenue of ₹172.22 Crore, a 43% year-on-year increase. PAT grew 42% to ₹29.09 Crore, driven by strategic acquisitions and API demand.

Value: ₹172.2 Cr

Read the filing ↗